Status
Conditions
Treatments
About
Examination if the bioimpendanz measurement can be used for the determination of the alcohol content in human blood.
Furthermore the blood alcohol content (BAC) will be estimated by an official breathalyzer and one blood test.
Full description
In this clinical trail it will be analyzed, if it is possible to assess the blood alcohol content (BAC) with the bioimpedance devices (SFB7, ImpediMed; Nicomo).
This technology is non-invasive an can be measured by using conductive electrodes, capacitive electrodes or inductive measurement systems.
The BIS-values will be compared with an official breathanalyzer (Alcotest 7110 Evidential MK III, Dräger, Lübeck, Germany).
Furthermore one blood sample will be taken and analyzed with the ADH method as the current gold standard at the end of the trail.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
12 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal